AbbVie’s tavapadon holds potential to become prominent treatment in dopamine agonist market: GlobalData Read more
Responsible antibiotic use: How the industry can lead the way for evidence-backed guidelines Read more
DREAM-HF trial results highlight Mesoblast’s potential to differentiate in HF space: GlobalData Read more